Tuesday, August 25, 2009

Call for papers for Cancer Informatics from Dr James Willey

On behalf of the Editorial Board I invite you to submit your next article to Cancer Informatics, an open access electronic journal published by Libertas Academica. The journal specializes in providing wide and open access to high quality manuscripts reporting bioinformatic analysis of molecular genetic and/or clinical data pertaining to human cancer risk, prevention, outcome or treatment response.

We accept original studies and thoughtful reviews, surveys, opinions, commentaries, techniques, and essays. All submitted articles will be considered and peer-reviewed.

We provide an efficient, constructive peer review of manuscripts, with an editorial decision in less than 2 weeks for 90% of the papers submitted. Since the journal is open access, dissemination of the work is rapid and is available to anyone with an internet connection, leading to wide exposure for your published article.

We look forward to receiving your manuscript.

What is the advantage to you of publishing in Cancer Informatics?
  • Full open access: everyone can read your article and you retain copyright in it
  • Publishing decision within 2 weeks of submission
  • Your paper will not be rejected due to lack of space and will be published immediately on acceptance
  • Prompt and fair peer review from two expert peer reviewers
  • Frequent updates on your paper’s status
  • Friendly responsive staff
What a previous author said:
"The publishing process of this journal was a most pleasant and productive experience. I was particularly impressed with the regular updates of the progress of my submission. Many other journals receive a submission and authors may not hear anything for months. I appreciate your notification policy."
In summary:

The advantages of a younger journal such as Cancer Informatics are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Next steps:

Yours sincerely,
Dr James C. Willey

Editor-in-Chief
Cancer Informatics